Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03946657Phase 4Completed
Phase 4, randomised, single-blind trial of sevoflurane and propofol injection (veterinary) in class III obesity (2 arms), sponsored by Ondokuz Mayıs University. Primary endpoints: Cerebral oxygen saturation, Arterial Blood Gas pH and 2 more. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03946657.